Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-22 4:26 pm Sale | 2024-01-18 | 13D | OPKO Health, Inc. OPK | Phillip Frost, M.D. | 244,703,683 33.900% | -7,723,710 (-3.06%) | Filing History |
| 2023-04-20 4:26 pm Purchase | 2023-04-12 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 3,558,602 14.300% | 701,459 (+24.55%) | Filing History |
| 2023-02-21 4:20 pm Purchase | 2023-02-10 | 13D | OPKO Health, Inc. OPK | Phillip Frost, M.D. | 252,427,393 31.900% | 11,835,241 (+4.92%) | Filing History |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | OPKO Health, Inc. OPK | VANGUARD GROUP INC | 41,120,494 5.320% | 5,395,070 (+15.10%) | Filing History |
| 2023-02-03 4:10 pm Purchase | 2023-01-26 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 2,857,143 11.600% | 432,900 (+17.86%) | Filing History |
| 2022-08-19 4:05 pm Purchase | 2022-06-24 | 13D | OPKO Health, Inc. OPK | Phillip Frost, M.D. | 240,592,152 30.900% | 10,868,689 (+4.73%) | Filing History |
| 2022-08-19 4:04 pm Purchase | 2022-06-24 | 13D | OPKO Health, Inc. OPK | HSIAO JANE PH D | 35,977,274 4.600% | 962,510 (+2.75%) | Filing History |
| 2022-06-29 4:05 pm Purchase | 2022-05-09 | 13D | OPKO Health, Inc. OPK | Zerhouni Elias A. | 39,781,126 5.800% | 39,781,126 (New Position) | Filing History |
| 2022-06-29 4:00 pm Purchase | 2022-05-09 | 13D | OPKO Health, Inc. OPK | Nabel Gary J. | 39,715,028 5.800% | 39,715,028 (New Position) | Filing History |
| 2022-05-09 4:39 pm Purchase | 2022-04-29 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 2,424,242 21.200% | 2,424,242 (New Position) | Filing History |
| 2022-03-09 5:18 pm Sale | 2022-02-28 | 13G | OPKO Health, Inc. OPK | BlackRock Inc. BLK | 33,966,215 4.980% | -424,697 (-1.23%) | Filing History |
| 2022-02-10 08:28 am Purchase | 2021-12-31 | 13G | OPKO Health, Inc. OPK | VANGUARD GROUP INC | 35,725,424 5.240% | 1,275,270 (+3.70%) | Filing History |
| 2022-02-01 5:08 pm Sale | 2021-12-31 | 13G | OPKO Health, Inc. OPK | BlackRock Inc. BLK | 34,390,912 5.000% | -3,325,921 (-8.82%) | Filing History |
| 2021-02-10 11:40 am Sale | 2020-12-31 | 13G | OPKO Health, Inc. OPK | VANGUARD GROUP INC | 34,450,154 5.140% | -3,094,496 (-8.24%) | Filing History |
| 2021-01-29 5:23 pm Purchase | 2020-12-31 | 13G | OPKO Health, Inc. OPK | BlackRock Inc. BLK | 37,716,833 5.600% | 1,594,783 (+4.41%) | Filing History |
| 2020-11-19 4:01 pm Purchase | 2020-11-13 | 13D | Cocrystal Pharma, Inc. COCP | OPKO HEALTH INC. OPK | 307,921 5.400% | 781 (+0.25%) | Filing History |